BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• Press Releases

  NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 for Suicidal Ideation in Patients with Depression, including Bipolar Depression

  August 12, 2025

   · 

  9 min read
• Press Releases

  Alnylam to Present Progress in Transforming the Treatment of Cardiovascular Disease with RNAi Therapeutics at European Society of Cardiology Congress 2025

  August 12, 2025

   · 

  12 min read
• Press Releases

  Cadrenal Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

  August 12, 2025

   · 

  10 min read
• Press Releases

  TriSalus Life Sciences Announces Publication of Safety and Efficacy Results for a Novel Pressure-Enabled Thyroid Embolization Technique

  August 12, 2025

   · 

  6 min read
• Press Releases

  SetPoint Medical Raises $140 Million in Private Financing and Expands Leadership Team to Support Commercialization of Rheumatoid Arthritis Therapy

  August 12, 2025

   · 

  3 min read
• Press Releases

  Oragenics Q2 2025 Shareholder Update

  August 12, 2025

   · 

  10 min read
• Press Releases

  Aptevo Therapeutics Reports 2Q25 Financial Results And Provides A Business Update

  August 12, 2025

   · 

  13 min read
• Press Releases

  Equillium Announces Up to $50 Million Financing to Advance EQ504, a Novel Aryl Hydrocarbon Receptor Modulator, into the Clinic

  August 12, 2025

   · 

  7 min read
• Press Releases

  Thermo Fisher Receives FDA Approval for NGS-Based Companion Diagnostic for New Non-Small Cell Lung Cancer Treatment

  August 12, 2025

   · 

  3 min read
• Press Releases

  ImmunityBio Announces Houston’s Michael E. DeBakey VA Medical Center Is Among the First VA Hospitals to Administer ANKTIVA® to Bladder Cancer Patients

  August 12, 2025

   · 

  8 min read